|What causes psychosis? An umbrella review of risk and protective factors|
J Radua, V Ramella‐Cravaro, JPA Ioannidis, A Reichenberg, ...
World Psychiatry 17 (1), 49-66, 2018
|Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis|
P Fusar-Poli, G Rutigliano, D Stahl, C Davies, I Bonoldi, T Reilly, ...
JAMA psychiatry 74 (5), 493-500, 2017
|Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis|
C Davies, A Cipriani, JPA Ioannidis, J Radua, D Stahl, U Provenzani, ...
World Psychiatry 17 (2), 196-209, 2018
|Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders|
P Fusar-Poli, G Rutigliano, D Stahl, C Davies, A De Micheli, ...
European Psychiatry 42, 49-54, 2017
|Cannabis-associated psychosis: Neural substrate and clinical impact|
RM Murray, A Englund, A Abi-Dargham, DA Lewis, M Di Forti, C Davies, ...
Neuropharmacology 124, 89-104, 2017
|Can we reduce the duration of untreated psychosis? A systematic review and meta-analysis of controlled interventional studies|
D Oliver, C Davies, G Crossland, S Lim, G Gifford, P McGuire, ...
Schizophrenia bulletin 44 (6), 1362-1372, 2018
|Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: a network meta-analysis|
C Davies, J Radua, A Cipriani, D Stahl, U Provenzani, P McGuire, ...
Frontiers in psychiatry 9, 187, 2018
|Transdiagnostic psychiatry: a systematic review|
P Fusar‐Poli, M Solmi, N Brondino, C Davies, C Chae, P Politi, ...
World Psychiatry 18 (2), 192-207, 2019
|Why transition risk to psychosis is not declining at the OASIS ultra high risk service: the hidden role of stable pretest risk enrichment|
P Fusar-Poli, E Palombini, C Davies, D Oliver, I Bonoldi, ...
Schizophrenia research 192, 385-390, 2018
|Transdiagnostic risk calculator for the automatic detection of individuals at risk and the prediction of psychosis: second replication in an independent national health service …|
P Fusar-Poli, N Werbeloff, G Rutigliano, D Oliver, C Davies, D Stahl, ...
Schizophrenia bulletin 45 (3), 562-570, 2019
|Diagnostic and prognostic significance of DSM-5 attenuated psychosis syndrome in services for individuals at ultra high risk for psychosis|
P Fusar-Poli, A De Micheli, M Cappucciati, G Rutigliano, C Davies, ...
Schizophrenia bulletin 44 (2), 264-275, 2018
|Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions|
G Rutigliano, S Merlino, A Minichino, R Patel, C Davies, D Oliver, ...
European Psychiatry 52, 126-133, 2018
|Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services|
A Minichino, G Rutigliano, S Merlino, C Davies, D Oliver, A De Micheli, ...
European Psychiatry 57, 26-32, 2019
|A case of a college student presenting with mild mental health problems|
P Fusar-Poli, C Davies, I Bonoldi
JAMA psychiatry 75 (12), 1298-1299, 2018
|What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors|
D Oliver, TJ Reilly, O Baccaredda Boy, N Petros, C Davies, S Borgwardt, ...
Schizophrenia bulletin 46 (1), 110-120, 2020
|Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis|
C Davies, Y Paloyelis, G Rutigliano, M Cappucciati, A De Micheli, ...
Neuropsychopharmacology 44 (7), 1300-1309, 2019
|Cannabidiol as a potential treatment for psychosis|
C Davies, S Bhattacharyya
Therapeutic advances in psychopharmacology 9, 2045125319881916, 2019
|Neurochemical effects of oxytocin in people at clinical high risk for psychosis|
C Davies, G Rutigliano, A De Micheli, JM Stone, V Ramella-Cravaro, ...
European Neuropsychopharmacology 29 (5), 601-615, 2019
|Transdiagnostic individualised clinically based risk calculator for the detection of individuals at risk and the prediction of psychosis: model refinement including non-linear …|
P Fusar-Poli, C Davies, G Rutigliano, D Stahl, I Bonoldi, P McGuire
Frontiers in psychiatry 10, 313, 2019
|34.1 DO ALL INDIVIDUALS WITH A FEP PASS THROUGH AN EARLIER CHR-P STATE? IMPLICATIONS FOR CLINICAL STAGING, EARLY DETECTION AND PHASE-SPECIFIC INTERVENTIONS|
J Shah, R Rosengard, S McIlwaine, S Mustafa, S Iyer, M Lepage, ...
Schizophrenia bulletin 44 (Suppl 1), S56, 2018